Pharmaceutical Companies Target Second-Tier Cities To Lower Costs

BMI View: Multinational pharmaceutical companies will increasingly look to China's second-tier cities as locations for their manufacturing plants, sales offices and, to a lesser extent, research facilities, primarily due to lower operations costs. These cities will also attract investors as regional governments are focusing on the biopharmaceutical sector as a key economic driver.

To read the full article, please choose one of the following options: